Dynamic factors controlling targeting nanocarriers to vascular endothelium.

Endothelium lining the luminal surface of blood vessels is the key target and barrier for vascular drug delivery. Nanocarriers coated with antibodies or affinity peptides that bind specifically to endothelial surface determinants provide targeted delivery of therapeutic cargoes to these cells. Endothelial targeting consists of several phases including circulation in the bloodstream, anchoring on the endothelial surface and, in some cases, intracellular uptake and trafficking of the internalized materials. Dynamic parameters of the vasculature including the blood hydrodynamics as well as surface density, accessibility, membrane mobility and clustering of target determinants modulate these phases of the targeting, especially anchoring to endothelium. Further, such controlled parameters of design of drug nanocarriers such as affinity, surface density and epitope specificity of targeting antibodies, carrier size and shape also modulate endothelial targeting and resultant sub-cellular addressing. This article reviews experimental and computational approaches for analysis of factors modulating targeting nanocarriers to the endothelial cells.

[1]  Vladimir Torchilin,et al.  Multifunctional and stimuli-sensitive pharmaceutical nanocarriers. , 2009, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[2]  T. W. Secomb,et al.  The endothelial surface layer , 2000, Pflügers Archiv.

[3]  D. Hammer,et al.  Characterization of biodegradable drug delivery vehicles with the adhesive properties of leukocytes. , 2002, Biomaterials.

[4]  Mohammad F. Kiani,et al.  Targeting Microparticles to Select Tissue via Radiation-Induced Upregulation of Endothelial Cell Adhesion Molecules , 2002, Pharmaceutical Research.

[5]  Simon C Watkins,et al.  Microbubbles targeted to intercellular adhesion molecule-1 bind to activated coronary artery endothelial cells. , 1998, Circulation.

[6]  V. Muzykantov,et al.  Slow intracellular trafficking of catalase nanoparticles targeted to ICAM-1 protects endothelial cells from oxidative stress. , 2003, American journal of physiology. Cell physiology.

[7]  G. Molema Tumor Vasculature Directed Drug Targeting: Applying New Technologies and Knowledge to the Development of Clinically Relevant Therapies , 2002, Pharmaceutical Research.

[8]  H. Harashima,et al.  Ligand-based targeted delivery of a peptide modified nanocarrier to endothelial cells in adipose tissue. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[9]  A. Malik,et al.  Signaling mechanisms regulating endothelial permeability. , 2006, Physiological reviews.

[10]  A. Al-Mehdi,et al.  Endothelial NADPH oxidase as the source of oxidants in lungs exposed to ischemia or high K+. , 1998, Circulation research.

[11]  V. Muzykantov,et al.  Targeting of antioxidant and anti-thrombotic drugs to endothelial cell adhesion molecules. , 2005, Current pharmaceutical design.

[12]  H. Shmeeda,et al.  Her2-targeted pegylated liposomal doxorubicin: retention of target-specific binding and cytotoxicity after in vivo passage. , 2009, Journal of controlled release : official journal of the Controlled Release Society.

[13]  V. Labhasetwar,et al.  Quantification of the force of nanoparticle-cell membrane interactions and its influence on intracellular trafficking of nanoparticles. , 2008, Biomaterials.

[14]  D. Hammer,et al.  Artificial polymeric cells for targeted drug delivery. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[15]  A. Geist,et al.  Protein dynamics and enzymatic catalysis: investigating the peptidyl-prolyl cis-trans isomerization activity of cyclophilin A. , 2004, Biochemistry.

[16]  A. Al-Mehdi,et al.  Simulated ischemia in flow-adapted endothelial cells leads to generation of reactive oxygen species and cell signaling. , 1999, Circulation research.

[17]  Kandaswamy Vijayan,et al.  Micelles of Different Morphologies—Advantages of Worm-like Filomicelles of PEO-PCL in Paclitaxel Delivery , 2007, Pharmaceutical Research.

[18]  J Szebeni,et al.  Stealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding properties. , 2003, Progress in lipid research.

[19]  A. Mulivor,et al.  Role of glycocalyx in leukocyte-endothelial cell adhesion. , 2002, American journal of physiology. Heart and circulatory physiology.

[20]  V. Muzykantov,et al.  Targeted delivery of therapeutics to endothelium , 2008, Cell and Tissue Research.

[21]  J. Loscalzo,et al.  Endothelial cells in physiology and in the pathophysiology of vascular disorders. , 1998, Blood.

[22]  E. Damiano The effect of the endothelial-cell glycocalyx on the motion of red blood cells through capillaries. , 1998, Microvascular research.

[23]  M Ferrari,et al.  Size and shape effects in the biodistribution of intravascularly injected particles. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[24]  S. Chien,et al.  Activation of Rac1 by shear stress in endothelial cells mediates both cytoskeletal reorganization and effects on gene expression , 2002, The EMBO journal.

[25]  M P Bevilacqua,et al.  Endothelial-leukocyte adhesion molecules. , 1993, Annual review of immunology.

[26]  H. Fusamoto,et al.  Expression of ICAM-1 is involved in the mechanism of liver injury during liver transplantation: therapeutic usefulness of the F(ab')2 fragment of an anti-ICAM-1 monoclonal antibody. , 1996, Transplantation proceedings.

[27]  J. Stoltz,et al.  Shear stress induces caveolin-1 translocation in cultured endothelial cells , 2002, European Biophysics Journal.

[28]  W. Jefferies,et al.  Transferrin receptor on endothelium of brain capillaries , 1984, Nature.

[29]  M Ferrari,et al.  Flow chamber analysis of size effects in the adhesion of spherical particles , 2007, International journal of nanomedicine.

[30]  V. Muzykantov,et al.  Optimizing endothelial targeting by modulating the antibody density and particle concentration of anti-ICAM coated carriers. , 2011, Journal of controlled release : official journal of the Controlled Release Society.

[31]  B. Duling,et al.  Capillary endothelial surface layer selectively reduces plasma solute distribution volume. , 2000, American journal of physiology. Heart and circulatory physiology.

[32]  P. Davies,et al.  Flow-mediated endothelial mechanotransduction. , 1995, Physiological reviews.

[33]  V. Muzykantov,et al.  Endothelial targeting of a recombinant construct fusing a PECAM-1 single-chain variable antibody fragment (scFv) with prourokinase facilitates prophylactic thrombolysis in the pulmonary vasculature. , 2005, Blood.

[34]  L. Glimcher,et al.  Differing regulation and function of ICAM-1 and class II antigens on renal tubular cells. , 1990, Kidney international.

[35]  Samir Mitragotri,et al.  Flow and adhesion of drug carriers in blood vessels depend on their shape: a study using model synthetic microvascular networks. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[36]  Silvia Muro,et al.  Flow dynamics, binding and detachment of spherical carriers targeted to ICAM-1 on endothelial cells. , 2009, Biorheology.

[37]  A. Gotlieb,et al.  Patterns of Endothelial Microfilament Distribution in the Rabbit Aorta In Situ , 1989, Circulation research.

[38]  Jacob Klein,et al.  Reduction of frictional forces between solid surfaces bearing polymer brushes , 1994, Nature.

[39]  V. Labhasetwar,et al.  Characterization of nanoparticle uptake by endothelial cells. , 2002, International journal of pharmaceutics.

[40]  Sei-Young Lee,et al.  Shaping nano-/micro-particles for enhanced vascular interaction in laminar flows , 2009, Nanotechnology.

[41]  D. Hallahan,et al.  Intercellular adhesion molecule 1 knockout abrogates radiation induced pulmonary inflammation. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[42]  Molly S. Shoichet,et al.  Tunable immunonanoparticle binding to cancer cells: thermodynamic analysis of targeted drug delivery vehicles , 2009 .

[43]  Aliasger K Salem,et al.  Leukocyte-inspired biodegradable particles that selectively and avidly adhere to inflamed endothelium in vitro and in vivo , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[44]  G. Bendas,et al.  VCAM-1 directed immunoliposomes selectively target tumor vasculature in vivo. , 2008, Biochimica et biophysica acta.

[45]  Alexander V Kabanov,et al.  Pluronic block copolymers as novel polymer therapeutics for drug and gene delivery. , 2002, Journal of controlled release : official journal of the Controlled Release Society.

[46]  S. Kennel,et al.  Vascular immunotargeting of glucose oxidase to the endothelial antigens induces distinct forms of oxidant acute lung injury: targeting to thrombomodulin, but not to PECAM-1, causes pulmonary thrombosis and neutrophil transmigration. , 2002, The American journal of pathology.

[47]  Phapanin Charoenphol,et al.  Potential role of size and hemodynamics in the efficacy of vascular-targeted spherical drug carriers. , 2010, Biomaterials.

[48]  Mauro Ferrari,et al.  Intravascular Delivery of Particulate Systems: Does Geometry Really Matter? , 2008, Pharmaceutical Research.

[49]  R. Duncan Polymer-Drug Conjugates: Targeting Cancer , 2002 .

[50]  D. Hammer,et al.  Interplay between rolling and firm adhesion elucidated with a cell-free system engineered with two distinct receptor-ligand pairs. , 2003, Biophysical journal.

[51]  P. Agarwal,et al.  Network of coupled promoting motions in enzyme catalysis , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[52]  Silvia Muro,et al.  Delivery of Acid Sphingomyelinase in Normal and Niemann-Pick Disease Mice Using Intercellular Adhesion Molecule-1-Targeted Polymer Nanocarriers , 2008, Journal of Pharmacology and Experimental Therapeutics.

[53]  Samir Mitragotri,et al.  Role of target geometry in phagocytosis. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[54]  D. Crommelin,et al.  Adhesion molecules: a new target for immunoliposome‐mediated drug delivery , 1995, FEBS letters.

[55]  Timothy A. Springer,et al.  Purified intercellular adhesion molecule-1 (ICAM-1) is a ligand for lymphocyte function-associated antigen 1 (LFA-1) , 1987, Cell.

[56]  Silvia Muro,et al.  Endothelial Targeting of High-Affinity Multivalent Polymer Nanocarriers Directed to Intercellular Adhesion Molecule 1 , 2006, Journal of Pharmacology and Experimental Therapeutics.

[57]  S. Milner Hydrodynamic penetration into parabolic brushes , 1991 .

[58]  M. Cybulsky,et al.  Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. , 1991, Science.

[59]  Samir Mitragotri,et al.  Particle shape: a new design parameter for micro- and nanoscale drug delivery carriers. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[60]  P Bongrand,et al.  Cell adhesion. Competition between nonspecific repulsion and specific bonding. , 1984, Biophysical journal.

[61]  W. Pardridge Molecular Trojan horses for blood-brain barrier drug delivery. , 2006, Discovery medicine.

[62]  T. Annecke,et al.  Therapeutic strategies targeting the endothelial glycocalyx: acute deficits, but great potential. , 2010, Cardiovascular research.

[63]  M. Tavassoli,et al.  Liver endothelium and not hepatocytes or Kupffer cells have transferrin receptors. , 1984, Blood.

[64]  R M Heethaar,et al.  Blood platelets are concentrated near the wall and red blood cells, in the center in flowing blood. , 1988, Arteriosclerosis.

[65]  G. Grest Normal and Shear Forces Between Polymer Brushes , 1999 .

[66]  P. Vanhoutte Endothelium-derived free radicals: for worse and for better. , 2001, The Journal of clinical investigation.

[67]  C. Berkland,et al.  ICAM-1 targeting of doxorubicin-loaded PLGA nanoparticles to lung epithelial cells. , 2009, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[68]  Alexander V Kabanov,et al.  Pluronic block copolymers: evolution of drug delivery concept from inert nanocarriers to biological response modifiers. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[69]  Tamar Schlick,et al.  Analysis of protein sequence/structure similarity relationships. , 2002, Biophysical journal.

[70]  V. Muzykantov,et al.  A novel endocytic pathway induced by clustering endothelial ICAM-1 or PECAM-1 , 2003, Journal of Cell Science.

[71]  Doriano Brogioli,et al.  Lipid-based nanoparticles with high binding affinity for amyloid-beta1-42 peptide. , 2010, Biomaterials.

[72]  V. Muzykantov,et al.  Synthetic Carriers for Vascular Delivery of Protein Therapeutics , 2006, Biotechnology & genetic engineering reviews.

[73]  E. Ruoslahti,et al.  Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model. , 1998, Science.

[74]  V. Muzykantov,et al.  Characterization of endothelial internalization and targeting of antibody-enzyme conjugates in cell cultures and in laboratory animals. , 2004, Methods in molecular biology.

[75]  R. Thrall,et al.  Early detection of oleic acid-induced lung injury in rats using (111)In-labeled anti-rat intercellular adhesion molecule-1. , 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[76]  A. Klibanov,et al.  Ligand-carrying gas-filled microbubbles: ultrasound contrast agents for targeted molecular imaging. , 2005, Bioconjugate chemistry.

[77]  M. Simionescu,et al.  Transcytosis of plasma macromolecules in endothelial cells: A cell biological survey , 2002, Microscopy research and technique.

[78]  M Ferrari,et al.  The receptor-mediated endocytosis of nonspherical particles. , 2008, Biophysical journal.

[79]  V. Muzykantov,et al.  Lysosomal enzyme delivery by ICAM-1-targeted nanocarriers bypassing glycosylation- and clathrin-dependent endocytosis. , 2006, Molecular therapy : the journal of the American Society of Gene Therapy.

[80]  T. Minko,et al.  Receptor targeted polymers, dendrimers, liposomes: which nanocarrier is the most efficient for tumor-specific treatment and imaging? , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[81]  Ianessa Morantte,et al.  Humanization of an anti-ICAM-1 antibody with over 50-fold affinity and functional improvement. , 2003, Journal of immunological methods.

[82]  R. Radhakrishnan,et al.  The Role of Glycocalyx in Nanocarrier-Cell Adhesion Investigated Using a Thermodynamic Model and Monte Carlo Simulations. , 2007, The journal of physical chemistry. C, Nanomaterials and interfaces.

[83]  D. Buerk,et al.  Immunotargeting of catalase to the pulmonary endothelium alleviates oxidative stress and reduces acute lung transplantation injury , 2003, Nature Biotechnology.

[84]  O. McCarty,et al.  Single Molecule Characterization of P-selectin/Ligand Binding* 210 , 2003, The Journal of Biological Chemistry.

[85]  Mauro Ferrari,et al.  Design maps for nanoparticles targeting the diseased microvasculature. , 2008, Biomaterials.

[86]  Samir Mitragotri,et al.  Role of Particle Size in Phagocytosis of Polymeric Microspheres , 2008, Pharmaceutical Research.

[87]  Daniel A Hammer,et al.  Selectin catch–slip kinetics encode shear threshold adhesive behavior of rolling leukocytes , 2008, Proceedings of the National Academy of Sciences.

[88]  V. Muzykantov,et al.  ICAM-1 recycling in endothelial cells: a novel pathway for sustained intracellular delivery and prolonged effects of drugs. , 2005, Blood.

[89]  K. Burridge,et al.  Leukocyte transendothelial migration: orchestrating the underlying molecular machinery. , 2001, Current opinion in cell biology.

[90]  G. Johnson,et al.  Ligand Regulates Epidermal Growth Factor Receptor Kinase Specificity , 2004, Journal of Biological Chemistry.

[91]  A. Mulivor,et al.  Inflammation- and ischemia-induced shedding of venular glycocalyx. , 2004, American journal of physiology. Heart and circulatory physiology.

[92]  S. Weinbaum,et al.  A hydrodynamic mechanosensory hypothesis for brush border microvilli. , 2000, American journal of physiology. Renal physiology.

[93]  S M Moghimi,et al.  Long-circulating and target-specific nanoparticles: theory to practice. , 2001, Pharmacological reviews.

[94]  D. Altieri,et al.  Apical topography and modulation of ICAM-1 expression on activated endothelium. , 1995, The American journal of pathology.

[95]  Daniel A Hammer,et al.  Quantifying nanoparticle adhesion mediated by specific molecular interactions. , 2008, Langmuir : the ACS journal of surfaces and colloids.

[96]  Denis Wirtz,et al.  Organization of Cellular Receptors into a Nanoscale Junction during HIV-1 Adhesion , 2010, PLoS Comput. Biol..

[97]  V. Muzykantov,et al.  Immunotargeting of catalase to ACE or ICAM-1 protects perfused rat lungs against oxidative stress. , 1998, American journal of physiology. Lung cellular and molecular physiology.

[98]  L. Cipelletti,et al.  Size-dependent intracellular immunotargeting of therapeutic cargoes into endothelial cells. , 2002, Blood.

[99]  V. Torchilin,et al.  p-Nitrophenylcarbonyl-PEG-PE-liposomes: fast and simple attachment of specific ligands, including monoclonal antibodies, to distal ends of PEG chains via p-nitrophenylcarbonyl groups. , 2001, Biochimica et biophysica acta.

[100]  Samir Mitragotri,et al.  Control of endothelial targeting and intracellular delivery of therapeutic enzymes by modulating the size and shape of ICAM-1-targeted carriers. , 2008, Molecular therapy : the journal of the American Society of Gene Therapy.

[101]  A. Beaudet,et al.  Role of the intercellular adhesion molecule-1(ICAM-1) in endotoxin-induced pneumonia evaluated using ICAM-1 antisense oligonucleotides, anti-ICAM-1 monoclonal antibodies, and ICAM-1 mutant mice. , 1996, The Journal of clinical investigation.

[102]  M. Cybulsky,et al.  Immunotargeting of liposomes to activated vascular endothelial cells: a strategy for site-selective delivery in the cardiovascular system. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[103]  Stephen C. Cowin,et al.  Mechanotransduction and flow across the endothelial glycocalyx , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[104]  G. I. Bell Models for the specific adhesion of cells to cells. , 1978, Science.

[105]  R. Rothlein,et al.  Integrins, ICAMs, and selectins: role and regulation of adhesion molecules in neutrophil recruitment to inflammatory sites. , 1994, Advances in pharmacology.

[106]  U. Welsch,et al.  GLYCOCALYX PROTECTION REDUCES LEUKOCYTE ADHESION AFTER ISCHEMIA/REPERFUSION , 2010, Shock.

[107]  Kenneth A. Dawson,et al.  Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts , 2008, Proceedings of the National Academy of Sciences.

[108]  M. Gimbrone,et al.  Vascular endothelium, hemodynamic forces, and atherogenesis. , 1999, The American journal of pathology.

[109]  S. Santra,et al.  Role of nanoparticle valency in the nondestructive magnetic-relaxation-mediated detection and magnetic isolation of cells in complex media. , 2009, Journal of the American Chemical Society.

[110]  S. Izumo,et al.  Fluid shear stress differentially modulates expression of genes encoding basic fibroblast growth factor and platelet-derived growth factor B chain in vascular endothelium. , 1993, The Journal of clinical investigation.

[111]  D. Hammer,et al.  I-domain of lymphocyte function-associated antigen-1 mediates rolling of polystyrene particles on ICAM-1 under flow. , 2005, Biophysical journal.

[112]  Daniel A Hammer,et al.  The state diagram for cell adhesion mediated by two receptors. , 2003, Biophysical journal.

[113]  S. Santra,et al.  Emerging nanotechnology-based strategies for the identification of microbial pathogenesis. , 2010, Advanced drug delivery reviews.

[114]  V. Muzykantov Immunotargeting of drugs to the pulmonary vascular endothelium as a therapeutic strategy , 1998 .

[115]  G. Whitesides The 'right' size in nanobiotechnology , 2003, Nature Biotechnology.